Sridhar VS - Search Results

1

Finerenone-A New Frontier in Renin-Angiotensin-Aldosterone System Inhibition in Diabetic Kidney Disease.

Sridhar VS, Liu H, Cherney DZI. Sridhar VS, et al. Am J Kidney Dis. 2021 Aug;78(2):309-311. doi: 10.1053/j.ajkd.2021.02.324. Epub 2021 Mar 19. Am J Kidney Dis. 2021. PMID: 33753202 No abstract available.

2

What have we learned about renal protection from the cardiovascular outcome trials and observational analyses with SGLT2 inhibitors?

Sridhar VS, Rahman HU, Cherney DZI. Sridhar VS, et al. Diabetes Obes Metab. 2020 Apr;22 Suppl 1:55-68. doi: 10.1111/dom.13965. Diabetes Obes Metab. 2020. PMID: 32267075 Review.

3

We Can Finally Stop Worrying About SGLT2 Inhibitors and Acute Kidney Injury.

Sridhar VS, Tuttle KR, Cherney DZI. Sridhar VS, et al. Am J Kidney Dis. 2020 Oct;76(4):454-456. doi: 10.1053/j.ajkd.2020.05.014. Epub 2020 Jul 22. Am J Kidney Dis. 2020. PMID: 32712014 No abstract available.

4

Making a case for the combined use of SGLT2 inhibitors and GLP1 receptor agonists for cardiorenal protection.

Sridhar VS, Dubrofsky L, Boulet J, Cherney DZ. Sridhar VS, et al. J Bras Nefrol. 2020 Oct-Dec;42(4):467-477. doi: 10.1590/2175-8239-JBN-2020-0100. J Bras Nefrol. 2020. PMID: 32926067 Free PMC article. Review.

5

Case - Reflex anuria: A rare complication of retrograde pyelography.

Dharia A, Sridhar V, Perlis N, Cherney D. Dharia A, et al. Can Urol Assoc J. 2021 Jul;15(7):E380-E382. doi: 10.5489/cuaj.7036. Can Urol Assoc J. 2021. PMID: 33382376 Free PMC article. No abstract available.

6

Relationships between inflammation, hemodynamic function and RAAS in longstanding type 1 diabetes and diabetic kidney disease.

Ambinathan JPN, Sridhar VS, Lytvyn Y, Lovblom LE, Liu H, Bjornstad P, Perkins BA, Lovshin JA, Cherney DZI. Ambinathan JPN, et al. Among authors: sridhar vs. J Diabetes Complications. 2021 May;35(5):107880. doi: 10.1016/j.jdiacomp.2021.107880. Epub 2021 Feb 2. J Diabetes Complications. 2021. PMID: 33678512

7

Cardiorenal Protection in Diabetic Kidney Disease.

Lee JF, Berzan E, Sridhar VS, Odutayo A, Cherney DZI. Lee JF, et al. Among authors: sridhar vs. Endocrinol Metab (Seoul). 2021 Apr;36(2):256-269. doi: 10.3803/EnM.2021.987. Epub 2021 Apr 19. Endocrinol Metab (Seoul). 2021. PMID: 33873265 Free PMC article. Review.

8

Sodium-glucose cotransporter 2 inhibition in non-diabetic kidney disease.

Almaimani M, Sridhar VS, Cherney DZI. Almaimani M, et al. Among authors: sridhar vs. Curr Opin Nephrol Hypertens. 2021 Sep 1;30(5):474-481. doi: 10.1097/MNH.0000000000000724. Curr Opin Nephrol Hypertens. 2021. PMID: 34074889 Review.

9

Changes in plasma and urine metabolites associated with empagliflozin in patients with type 1 diabetes.

Liu H, Sridhar VS, Montemayor D, Lovblom LE, Lytvyn Y, Ye H, Kim J, Ali MT, Scarr D, Lawler PR, Perkins BA, Sharma K, Cherney DZI. Liu H, et al. Among authors: sridhar vs. Diabetes Obes Metab. 2021 Nov;23(11):2466-2475. doi: 10.1111/dom.14489. Epub 2021 Jul 28. Diabetes Obes Metab. 2021. PMID: 34251085

10

Cardiometabolic and Kidney Protection in Kidney Transplant Recipients With Diabetes: Mechanisms, Clinical Applications, and Summary of Clinical Trials.

Sridhar VS, Ambinathan JPN, Gillard P, Mathieu C, Cherney DZI, Lytvyn Y, Singh SK. Sridhar VS, et al. Transplantation. 2022 Apr 1;106(4):734-748. doi: 10.1097/TP.0000000000003919. Transplantation. 2022. PMID: 34381005 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters